1
|
Virag P, Hedesiu M, Soritau O, Perde-Schrepler M, Brie I, Pall E, Fischer-Fodor E, Bogdan L, Lucaciu O, Belmans N, Moreels M, Salmon B, Jacobs R. Low-dose radiations derived from cone-beam CT induce transient DNA damage and persistent inflammatory reactions in stem cells from deciduous teeth. Dentomaxillofac Radiol 2018; 48:20170462. [PMID: 30168750 DOI: 10.1259/dmfr.20170462] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
OBJECTIVES Cone-beam CT (CBCT), a radiographic tool for diagnosis, treatment, and follow-up in dental practice, was introduced also in pediatric radiology, especially orthodontics. Such patients subjected to repetitive X-rays examinations may receive substantial levels of radiation doses. Ionizing radiation (IR), a recognized carcinogenic factor causing DNA double-strand breaks (DSBs) could be harmful to undifferentiated cells such as dental pulp stem cells (DPSCs) since inaccurately repaired or unrepaired DSBs may lead to malignant transformation. The H2AX and MRE11 proteins generated following DSBs formation and pro-inflammatory cytokines (CKs) secreted after irradiation are relevant candidates to monitor the cellular responses induced by CBCT. METHODS DPSCs were extracted from human exfoliated deciduous teeth and their phenotype was assessed by immunocytochemistry and flow-cytometry. Cells were exposed to IR doses: 5.4-107.7 mGy, corresponding to 0.5-8 consecutive skull exposures, respectively. H2AX and MRE11 were detected in whole cells, while IL-1α, IL-6, IL-8, TNFα in supernatants, using enzyme-linked immunosorbent assay (ELISA) at different time points after exposure. RESULTS The phosphorylation level of H2AX in DPSCs increased considerably at 0.5 h after exposure (p < 0.001 for 3, 5, 8 skull exposures and p < 0.05 for 1 skull exposure, respectively). MRE11 response could only be detected for the highest IR dose (p < 0.001) in the same interval. CKs secretion increased upon CBCT exposure according to doses and time. CONCLUSIONS The DPSCs exposure to CBCT induces transient DNA damage and persistent inflammatory reaction in DPSCs drawing the attention on the potential risks of IR exposures and on the importance of dose monitoring in pediatric population.
Collapse
Affiliation(s)
- Piroska Virag
- The Oncology Institute "Prof.Dr.Ion Chiricuta", Laboratory of Radiotherapy, Radiobiology and Tumor Biology, Cluj-Napoca, Romania
| | - Mihaela Hedesiu
- "Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Oral and Maxillofacial Radiology, Cluj-Napoca, Romania
| | - Olga Soritau
- The Oncology Institute "Prof.Dr.Ion Chiricuta", Laboratory of Radiotherapy, Radiobiology and Tumor Biology, Cluj-Napoca, Romania
| | - Maria Perde-Schrepler
- The Oncology Institute "Prof.Dr.Ion Chiricuta", Laboratory of Radiotherapy, Radiobiology and Tumor Biology, Cluj-Napoca, Romania
| | - Ioana Brie
- The Oncology Institute "Prof.Dr.Ion Chiricuta", Laboratory of Radiotherapy, Radiobiology and Tumor Biology, Cluj-Napoca, Romania
| | - Emoke Pall
- University of Agricultural Sciences and Veterinary Medicine, Cluj- Napoca, Romania
| | - Eva Fischer-Fodor
- The Oncology Institute "Prof.Dr.Ion Chiricuta", Laboratory of Radiotherapy, Radiobiology and Tumor Biology, Cluj-Napoca, Romania.,"Iuliu Hatieganu" University of Medicine and Pharmacy, Medfuture Research Center for Advanced Medicine, Cluj-Napoca, Romania
| | - Loredana Bogdan
- Radiation Hygiene Department, National Institute of Public Health, Regional Center of Public Health Cluj-Napoca, Cluj-Napoca, Romania
| | - Ondine Lucaciu
- "Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Oral and Maxillofacial Radiology, Cluj-Napoca, Romania
| | - Niels Belmans
- Faculty of Medicine and Life Sciences, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.,Radiobiology Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre, SCK·CEN, Boeretang, Belgium
| | - Marjan Moreels
- Radiobiology Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre, SCK·CEN, Boeretang, Belgium
| | - Benjamin Salmon
- EA2496, Orofacial Pathologies, Imaging and Biotherapies, Dental School Paris Descartes University, Sorbonne Paris Cité, France.,Department of Odontology, AP-HP, Nord Val de Seine Hospital (Bretonneau), Paris, France
| | - Reinhilde Jacobs
- Department of Imaging and Pathology, OMFS-IMPATH Research Group, University of Leuven, Leuven, Belgium
| |
Collapse
|
2
|
Cahoon EK, Preston DL, Pierce DA, Grant E, Brenner AV, Mabuchi K, Utada M, Ozasa K. Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009. Radiat Res 2017; 187:538-548. [PMID: 28323575 PMCID: PMC5505071 DOI: 10.1667/rr14583.1] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The Life Span Study (LSS) of Japanese atomic bomb survivors is comprised of a large, population-based cohort offering one of the best opportunities to study the relationship between exposure to radiation and incidence of respiratory cancers. Risks of lung, laryngeal and other cancers of the respiratory system were evaluated among 105,444 LSS subjects followed from 1958 to 2009. During this period, we identified 2,446 lung, 180 laryngeal and 115 other respiratory (trachea, mediastinum and other ill-defined sites) first primary incident cancer cases. Ten additional years of follow-up, improved radiation dose estimates, revised smoking data, and updated migration information were used to investigate the joint effects of radiation and smoking using Poisson regression methods. For nonsmokers, the sex-averaged excess relative risk per Gy (ERR/Gy) for lung cancer (at age 70 after radiation exposure at age 30) was estimated as 0.81 (95% CI: 0.51, 1.18) with a female-to-male ratio of 2.83. There was no evidence of curvature in the radiation dose-response relationship overall or by sex. Lung cancer risks increased with pack-years of smoking and decreased with time since quitting smoking at any level of radiation exposure. Similar to the previously reported study, which followed cohort members through 1999, the ERR/Gy for lung cancer was significantly higher for low-to-moderate smokers than for heavy smokers, with little evidence of any radiation-associated excess risk in heavy smokers. Of 2,446 lung cancer cases, 113 (5%) could be attributed to radiation exposure. Of the 1,165 lung cancer cases occurring among smokers, 886 (76%) could be attributed to smoking. While there was little evidence of a radiation effect for laryngeal cancer, a nonsignificantly elevated risk of other respiratory cancers was observed. However, significant smoking effects were observed for both laryngeal (ERR per 50 pack-years = 23.57; 95% CI: 8.44, 71.05) and other respiratory cancers (ERR per 50 pack-years = 1.21; 95% CI: 0.10, 3.25).
Collapse
Affiliation(s)
- Elizabeth K. Cahoon
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | | | - Donald A. Pierce
- Division of Biostatistics, Department of Public Health and Preventive Medicine, Oregon Health and Sciences University, Portland, Oregon
| | - Eric Grant
- Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan
| | - Alina V. Brenner
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - Kiyohiko Mabuchi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
| | - Mai Utada
- Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan
| | - Kotaro Ozasa
- Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan
| |
Collapse
|
3
|
Doi Y, Murakami Y, Kenjo M, Imano N, Kimura T, Nagata Y. Evaluation of adverse events in atomic bomb survivors receiving curative-intent radiation therapy from 2005 to 2010. Radiother Oncol 2016; 118:60-4. [DOI: 10.1016/j.radonc.2015.11.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2014] [Accepted: 11/26/2015] [Indexed: 10/22/2022]
|